|
 Pharmaceutical Name: Biological (not pharmaceutical): Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Tetani-Perfringens Types C & D Bacterin-Toxoid
Description:
Features & Benefits:
provides clostridial protection against eight clostridial diseases.
For vaccination of healthy cattle and sheep against diseases caused by Cl. chauvoei, Cl. septicum, Cl. novyi Type B, C. haemolyticum (known elsewhere as Cl. novyi Type D), Cl. tetani and Cl. perfringens Types C & D.
Easy-to-use delivery system offers the highest level of convenience while minimizing the chances for contamination.
Antigens produced by Electroferm, electronically-controlled deep culture process.
Packaging is highly flexible, stackable and collapsible for easier use, storage and disposal.
Indications:
For the vaccination of healthy cattle and sheep against diseases caused by Clostridium chauvoei, Cl. septicum, Cl. novyi Type B, Cl. haemolyticum (known elsewhere as Cl. novyi Type D), Cl. tetani and Cl. perfringens Types C and D.
Although Clostridium perfringens Type B is not considered a significant problem in the U.S.A., immunity may be provided against the beta and epsilon toxins elaborated by Cl. perfringens Type B. The immunity is derived from the combination of Type C (beta) and Type D (epsilon) fractions.
Dosage:
For further information including dose rate and complete directions and warnings, please see the Product Label.
Covexin 8 is a registered trademark of Schering-Plough Animal Health Corporation. | 
